Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Mydecine Innovations Group Inc
(OP:
MYCOF
)
0.0106
+0.0004 (+3.92%)
Streaming Delayed Price
Updated: 11:35 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mydecine Innovations Group Inc
< Previous
1
2
3
4
5
6
7
Next >
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Finishing Up Significant 2021 Calendar Year
December 07, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Patent Application Covering Multiple Families of Psilocin Analogs
December 06, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
December 01, 2021
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Reimagining Mental Health, Addiction Treatment
December 01, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Releases Q3 Update, Details JHU Five-Year Research Agreement
December 01, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Excited for Seamless Phase 2/3 Clinical Research as Dr. Matthew Johnson Presents Interim Results of Current Smoking Cessation Study at the Psychedelic Medicine Business Event: Wonderland
November 22, 2021
Via
Investor Brand Network
Psychedelic Drug Stocks Continued To Decline Last Week
November 21, 2021
The 12 constituents in our Pure-Play Psychedelic Compounds-Based Drug Stocks Index declined -5.7% last week; it's now -16.1% so far in November.
Via
Talk Markets
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CEO Discusses Blockbuster Drug Potential on MidasLetter Podcast
November 18, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Featured in ROTH Equity Research Report
November 17, 2021
Via
Investor Brand Network
Mydecine: Q3 Financials, Advances Research On Psychedelic Therapies For Mental Health & Addiction Disorders
November 16, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC:MYCOF) (FSE: 0NF...
Via
Benzinga
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations
November 15, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelic Drug Stocks Have Plunged -10.6%, On Average, So Far In November
November 14, 2021
Our Pure-Play Psychedelic Compounds-Based Drug Stocks Index has declined -10.6% in the last 2 weeks; it's still up +7.8% since the end of September.
Via
Talk Markets
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CMO to Participate in Horizons’ Veterans & Families Forum
November 10, 2021
Via
Investor Brand Network
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Validates its AI-Driven Drug Discovery Program with Successful Synthesis of Novel Tryptamine; Confirms Participation in the Wonderland: Miami Psychedelic Medicine Business Event
November 05, 2021
Via
Investor Brand Network
NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon
November 04, 2021
Via
Investor Brand Network
The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine
November 04, 2021
Dr. Aaron T. Beck, the father of cognitive therapy, died on Monday at his home in Philadelphia at age 100. Beck&rsq...
Via
Benzinga
Topics
Death
Exposures
Death
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Files Patent Covering Formulations Featuring Nanoemulsion
November 03, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelics Offer Hope for Mental Disorders, Addiction
November 03, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Why Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Is ‘One to Watch’
November 02, 2021
Via
Investor Brand Network
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More
November 01, 2021
Via
Investor Brand Network
InvestorNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Participation in November Event
October 29, 2021
Via
Investor Brand Network
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Is ‘One to Watch’
October 27, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Successfully Synthesizes Novel Psilocin Analogue
October 27, 2021
Via
Investor Brand Network
Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148%
October 24, 2021
The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD.
Via
Talk Markets
Historic: Federal Agency Awards Grant For Psychedelics Research, First Time In 50 years
October 20, 2021
The National Institutes of Health awarded a nearly $4 million grant meant to fund research on psilocybin, the act...
Via
Benzinga
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021
October 15, 2021
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.
Via
Talk Markets
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
October 01, 2021
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Psychedelics Called the ‘Next Frontier’ for Investors, Also Offer Promising Treatments
September 29, 2021
Via
Investor Brand Network
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
October 14, 2021
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the...
Via
FinancialNewsMedia
Exposures
COVID-19
Mydecine On Verge Of Finalizing Spin-Out Of Cannabis Subsidiaries, Obtains Shareholder And Court Approval
September 27, 2021
Psychedelics and mycology company Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.